FAK activity in cancer‐associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer
Sonia Zaghdoudi(Centre National de la Recherche Scientifique), Christine Jean(Centre National de la Recherche Scientifique), Muriel Mathonnet(Inserm), Oliver M.T. Pearce(Queen Mary University of London), Manon Strehaïano(Université Toulouse III - Paul Sabatier), Aurélie Perraud(Centre Hospitalier Universitaire de Limoges), Ismahane Belhabib(Centre National de la Recherche Scientifique), Alexia Brunel(Université Toulouse III - Paul Sabatier), Amandine Alard(Unknown), Vinothini Rajeeve(Queen Mary University of London), Stéphanie Cassant‐Sourdy(Université Toulouse III - Paul Sabatier), Richard Tomasini(Centre de Recherche en Cancérologie de Marseille), Stéphane Pyronnet(Centre National de la Recherche Scientifique), Jérôme Cros(Université Paris Cité), Rémi Samain(Inserm), Corinne Bousquet(Centre National de la Recherche Scientifique), Yvan Martineau(Centre National de la Recherche Scientifique), Emilie Decaup(Université Toulouse III - Paul Sabatier), Julia Rochotte(Université Toulouse III - Paul Sabatier), David D. Schlaepfer(Moores Cancer Center), Cindy Neuzillet
Cited by 105
Related Papers
Differential regulation of cell motility and invasion by FAK
|The Journal of Cell Biology|2003|530
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Sialic acids in cancer biology and immunity
|Glycobiology|2015|463
Fibronectin-Stimulated Signaling from a Focal Adhesion Kinase–c-Src Complex: Involvement of the Grb2, p130 <sup> <i>cas</i> </sup> , and Nck Adaptor Proteins
|Molecular and Cellular Biology|1997|432
Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions
|Nature Communications|2017|403